<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>36-ANAGRELIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ANAGRELIDE" rxcui="596724">
<ATC code="L01XX35" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="ACETYLSALICYLIC ACID" rxcui="1191">
<ATC code="A01AD05" />
<ATC code="B01AC06" />
<ATC code="N02BA01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of hemorrhagic events </DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>36-ANAGRELIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ANAGRELIDE" rxcui="596724">
<ATC code="L01XX35" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="PLATELET AGGREGATION INHIBITORS" code="B01AC-001" /></DRUG2>
<DESCRIPTION>Increase of hemorraghic events </DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>36-ANAGRELIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ANAGRELIDE" rxcui="596724">
<ATC code="L01XX35" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="MEDICATIONS THAT TEND TO INDUCE TORSADES DE POINTES" code="C01-N05" /></DRUG2>
<DESCRIPTION>Increased risk of ventricular arrhythmias, especially of torsades de pointes</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
</INTERACTIONS>
